Why the study?
Is lower GLS associated with subclinical brain disease in a community-based cohort without overt cardiac disease?
Is lower GLS associated with subclinical brain disease in a community-based cohort without overt cardiac disease?
GLS provides additional information on cerebrovascular risk burden beyond LVEF assessment in patients without overt cardiac disease.
May inform cerebrovascular risk beyond LVEF; hypothesis-generating for GLS in community cohorts without overt cardiac disease.
Lower GLS was independently associated with subclinical brain disease in a community-based cohort without overt cardiac disease. GLS can provide additional information on cerebrovascular risk burden beyond LVEF assessment.
No takes yet. Share an insight, caveat, or question.
Russo et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: